SECURITIES AND EXCHANGE COMMISSION
                           Washington, D.C. 20549
                     ----------------------------------


                                  FORM 8-K

                               CURRENT REPORT
                   PURSUANT TO SECTION 13 OR 15(d) OF THE
                      SECURITIES EXCHANGE ACT OF 1934




                               April 5, 2002
              Date of report (date of earliest event reported)



                           QUADRAMED CORPORATION
             (Exact Name of Registrant as Specified in Charter)

          Delaware                  0-21031                     52-1992861

      (State or Other         (Commission File Number)        (IRS Employer
        Jurisdiction                                        Identification No.)
     of Incorporation)


               22 Pelican Way, San Rafael, California, 94901
               --------------------------------------------
                  (Address of Principal Executive Offices)



                               (415) 482-2100
                               --------------
            (Registrant's telephone number, including area code)









ITEM 4.

Changes in Registrant's Certifying Accountant.
---------------------------------------------

With the approval of the Audit Committee, QuadraMed has changed its
independent public accountants twice in the past two fiscal years.
QuadraMed and Arthur Andersen LLP ("Andersen") mutually agreed to
Andersen's resignation as QuadraMed's independent accountants on March 27,
2000. Andersen had served as QuadraMed's independent public accountants for
fiscal years 1998 and 1999 and prior periods. Pisenti & Brinker, LLP
("P&B"), appointed on May 8, 2000, has served as QuadraMed's independent
public accountants for fiscal years 2000 and 2001 and subsequent interim
periods. On April 5, 2002 PricewaterhouseCoopers, LLP ("PwC") was appointed
as QuadraMed's independent public accountants for fiscal year ending
December 31, 2002 and ratification of that appointment is now sought. Both
(a) Andersen's reports on QuadraMed's financial statements for the fiscal
years 1998 and 1999 and any subsequent interim period and (b) P&B's reports
on QuadraMed's financial statements for the fiscal years 2000 and 2001 and
any subsequent interim period did not contain an adverse opinion or a
disclaimer of opinion, and were not qualified or modified as to
uncertainty, audit scope, or accounting principles.

There were no disagreements between QuadraMed and its independent public
accountants on any matters of accounting principles or practices, financial
statement disclosure, or auditing scope or procedures, which disagreements,
if not resolved to the satisfaction of its independent public accountants,
would have caused them to make reference to the subject matter of such
disagreements in connection with their reports (a) during QuadraMed's
fiscal years 1998 and 1999 and through March 27, 2000, with respect to
Andersen; and (b) during QuadraMed's fiscal years 2000 and 2001 and any
subsequent interim period with respect to P&B.

In addition, (a) during QuadraMed's fiscal years 1998 and 1999 and through
March 27, 2000, with respect to Andersen, and (b) during QuadraMed's fiscal
years 2000 and 2001 and any subsequent interim period with respect to P&B,
QuadraMed was never advised that:

         1.    The internal controls necessary for QuadraMed to develop
               reliable financial statements did not exist.

         2.    Information had come to the attention of the independent
               public accountants that led them to no longer be able to
               rely on management's representations, or that made them
               unwilling to be associated with the financial statements
               prepared by management.

         3.    There was a need to expand significantly the scope of an
               audit, or that information had come to the attention of the
               independent public accountants during such period that, if
               further investigated, may (i) materially impact the fairness
               or reliability of previously issued financial statements and
               Reports of Independent Auditors, or the financial statements
               issued or to be issued covering the fiscal period(s)
               subsequent to the date of the most recent financial
               statements covered by an audit report, or (ii) cause the
               independent accountants to be unwilling to rely on
               management's representations or be associated with
               QuadraMed's financial statements.

         4.    Information had come to the attention of the independent
               public accountants that they had concluded materially
               impacted the fairness or reliability of previously issued
               financial statements and Reports of Independent Auditors, or
               the financial statements issued or to be issued covering the
               fiscal period(s) subsequent to the date of the most recent
               financial statements covered by an audit report.

QuadraMed provided Andersen with a copy of these disclosures and asked
Andersen to provide it with a letter addressed to the Securities and
Exchange Commission stating whether it agreed with QuadraMed's disclosures
and, if not, to specify in which respects it did not agree. A copy of
Andersen's letter was filed previously with the Securities and Exchange
Commission as Exhibit 16.2 to QuadraMed's Current Report on Form 8-K dated
March 31, 2000.

QuadraMed provided P&B with a copy of these disclosures and asked P&B to
provide it with a letter addressed to the Securities and Exchange
Commission stating whether it agreed with QuadraMed's disclosures and, if
not, to specify in which respects it did not agree. A copy of P&B's letter
has been filed with the Securities and Exchange Commission as Exhibit 16.1
to QuadraMed's Current Report on Form 8-K dated April 5, 2002.


ITEM 7.  Exhibits.
         --------

         Exhibit No.          Description

         16.1                 Letter dated April 5, 2002 from Pisenti &
                              Brinker, LLP.

                                 SIGNATURES

              Pursuant to the requirements of the Securities Exchange Act
of 1934, the Registrant has duly caused this report to be signed on its
behalf by the undersigned thereunto duly authorized.




Date: April 5, 2002                     By:  /s/ Mark N. Thomas
                                           __________________________________
                                           Name: Mark N. Thomas
                                           Title: Chief Financial Officer
                                                  (Principal Financial and
                                                  Accounting Officer)




                                                              EXHIBIT 16.1


                           PISENTI & BRINKER LLP
                              1318 Redwood Way
                                 Suite 210
                             Petaluma, CA 94954



April 5, 2002

Office of the Chief Accountant
Securities and Exchange Commission
450 Fifth Street, N.W.
Washington, DC 20549

Ladies and Gentlemen:

We have read the paragraphs of Item 4 included in the Form 8-K dated April
5, 2002 of QuadraMed Corporation to be filed with the Securities and
Exchange Commission and are in agreement with the statements contained
therein.


Very truly yours,



/s/ Pisenti & Brinker, LLP
-----------------------------
Pisenti & Brinker, LLP
[{"type": "8-K", "sequence": "1", "filename": "s8kchange.txt", "description": "8-K", "secsgml_size_bytes": 7672}]
{"company-data": {"conformed-name": "QUADRAMED CORP", "cik": "0001018833", "assigned-sic": "7371", "irs-number": "521992861", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-21031", "film-number": "02602791"}, "business-address": {"street1": "22 PELICAN WAY", "street2": "2ND FLOOR", "city": "SAN RAFAEL", "state": "CA", "zip": "94901", "phone": "4154822100"}, "mail-address": {"street1": "1003 WEST CUTTING BLVD", "street2": "2ND FLOOR", "city": "RICHMOND", "state": "CA", "zip": "94804"}}
SECURITIES AND EXCHANGE COMMISSION
                           Washington, D.C. 20549
                     ----------------------------------

                                  FORM 8-K

                               CURRENT REPORT
                   PURSUANT TO SECTION 13 OR 15(d) OF THE
                      SECURITIES EXCHANGE ACT OF 1934

                               April 5, 2002
              Date of report (date of earliest event reported)

                           QUADRAMED CORPORATION
             (Exact Name of Registrant as Specified in Charter)

          Delaware                  0-21031                     52-1992861

      (State or Other         (Commission File Number)        (IRS Employer
        Jurisdiction                                        Identification No.)
     of Incorporation)

               22 Pelican Way, San Rafael, California, 94901
               --------------------------------------------
                  (Address of Principal Executive Offices)

                               (415) 482-2100
                               --------------
            (Registrant's telephone number, including area code)

ITEM 4.

Changes in Registrant's Certifying Accountant.
---------------------------------------------

With the approval of the Audit Committee, QuadraMed has changed its
independent public accountants twice in the past two fiscal years.
QuadraMed and Arthur Andersen LLP ("Andersen") mutually agreed to
Andersen's resignation as QuadraMed's independent accountants on March 27,
2000. Andersen had served as QuadraMed's independent public accountants for
fiscal years 1998 and 1999 and prior periods. Pisenti & Brinker, LLP
("P&B"), appointed on May 8, 2000, has served as QuadraMed's independent
public accountants for fiscal years 2000 and 2001 and subsequent interim
periods. On April 5, 2002 PricewaterhouseCoopers, LLP ("PwC") was appointed
as QuadraMed's independent public accountants for fiscal year ending
December 31, 2002 and ratification of that appointment is now sought. Both
(a) Andersen's reports on QuadraMed's financial statements for the fiscal
years 1998 and 1999 and any subsequent interim period and (b) P&B's reports
on QuadraMed's financial statements for the fiscal years 2000 and 2001 and
any subsequent interim period did not contain an adverse opinion or a
disclaimer of opinion, and were not qualified or modified as to
uncertainty, audit scope, or accounting principles.

There were no disagreements between QuadraMed and its independent public
accountants on any matters of accounting principles or practices, financial
statement disclosure, or auditing scope or procedures, which disagreements,
if not resolved to the satisfaction of its independent public accountants,
would have caused them to make reference to the subject matter of such
disagreements in connection with their reports (a) during QuadraMed's
fiscal years 1998 and 1999 and through March 27, 2000, with respect to
Andersen; and (b) during QuadraMed's fiscal years 2000 and 2001 and any
subsequent interim period with respect to P&B.

In addition, (a) during QuadraMed's fiscal years 1998 and 1999 and through
March 27, 2000, with respect to Andersen, and (b) during QuadraMed's fiscal
years 2000 and 2001 and any subsequent interim period with respect to P&B,
QuadraMed was never advised that:

         1.    The internal controls necessary for QuadraMed to develop
               reliable financial statements did not exist.

         2.    Information had come to the attention of the independent
               public accountants that led them to no longer be able to
               rely on management's representations, or that made them
               unwilling to be associated with the financial statements
               prepared by management.

         3.    There was a need to expand significantly the scope of an
               audit, or that information had come to the attention of the
               independent public accountants during such period that, if
               further investigated, may (i) materially impact the fairness
               or reliability of previously issued financial statements and
               Reports of Independent Auditors, or the financial statements
               issued or to be issued covering the fiscal period(s)
               subsequent to the date of the most recent financial
               statements covered by an audit report, or (ii) cause the
               independent accountants to be unwilling to rely on
               management's representations or be associated with
               QuadraMed's financial statements.

         4.    Information had come to the attention of the independent
               public accountants that they had concluded materially
               impacted the fairness or reliability of previously issued
               financial statements and Reports of Independent Auditors, or
               the financial statements issued or to be issued covering the
               fiscal period(s) subsequent to the date of the most recent
               financial statements covered by an audit report.

QuadraMed provided Andersen with a copy of these disclosures and asked
Andersen to provide it with a letter addressed to the Securities and
Exchange Commission stating whether it agreed with QuadraMed's disclosures
and, if not, to specify in which respects it did not agree. A copy of
Andersen's letter was filed previously with the Securities and Exchange
Commission as Exhibit 16.2 to QuadraMed's Current Report on Form 8-K dated
March 31, 2000.

QuadraMed provided P&B with a copy of these disclosures and asked P&B to
provide it with a letter addressed to the Securities and Exchange
Commission stating whether it agreed with QuadraMed's disclosures and, if
not, to specify in which respects it did not agree. A copy of P&B's letter
has been filed with the Securities and Exchange Commission as Exhibit 16.1
to QuadraMed's Current Report on Form 8-K dated April 5, 2002.

ITEM 7.  Exhibits.
         --------

         Exhibit No.          Description

         16.1                 Letter dated April 5, 2002 from Pisenti &
                              Brinker, LLP.

                                 SIGNATURES

              Pursuant to the requirements of the Securities Exchange Act
of 1934, the Registrant has duly caused this report to be signed on its
behalf by the undersigned thereunto duly authorized.

Date: April 5, 2002                     By:  /s/ Mark N. Thomas
                                           __________________________________
                                           Name: Mark N. Thomas
                                           Title: Chief Financial Officer
                                                  (Principal Financial and
                                                  Accounting Officer)

                                                              EXHIBIT 16.1

                           PISENTI & BRINKER LLP
                              1318 Redwood Way
                                 Suite 210
                             Petaluma, CA 94954

April 5, 2002

Office of the Chief Accountant
Securities and Exchange Commission
450 Fifth Street, N.W.
Washington, DC 20549

Ladies and Gentlemen:

We have read the paragraphs of Item 4 included in the Form 8-K dated April
5, 2002 of QuadraMed Corporation to be filed with the Securities and
Exchange Commission and are in agreement with the statements contained
therein.

Very truly yours,

/s/ Pisenti & Brinker, LLP
-----------------------------
Pisenti & Brinker, LLP